Beta Bionics
Beta Bionics is a biotechnology company that develops an integrated bionic pancreas system called the iLet. Beta Bionics raised US$60M in Series E funding.
Email and contact information
Company website: www.betabionics.com
Decision maker info and email: SIGNUP TO UNBLOCK
Headquarters: Irvine, (United States)
Industry: Biotechnology
Business model: B2B
Funding
- Total funding amount: $60,000,000 (in USD)
- Estimated valuation: $300,000,000.00
- Latest deal type: Series E
- First fundind year: 2024
Growth
Founders:
Top investors:
Team size: SIGNUP TO UNBLOCK
Revenue: SIGNUP TO UNBLOCK